Trends & Events 📰
Top trends and catalysts shaping the U.S. stock market during the week of September 11th through 17th, 2024:
Nvidia and Big Tech Surge: Nvidia led the tech rally this week, rebounding sharply after recent losses. Boosted by strong demand for its AI products and analyst recommendations, Nvidia's stock gained nearly 16% by the end of the week. This helped drive the Nasdaq Composite up by 4.2%, its best week of the year. Other tech giants, including Microsoft and Apple, also contributed to the broader market gains. [1],[2]
Fed Rate Cut Bets Cool: Inflation data released on September 11th showed rising rent costs, which tempered expectations of an aggressive Federal Reserve rate cut in their upcoming meeting. Traders dialed back their bets on a half-point cut, now favoring a smaller quarter-point adjustment in September, with more significant cuts expected later in the year. [1]
Arm Holdings' Strong Performance: Arm Holdings continued its strong momentum, gaining 6% on Friday following bullish analyst coverage. The company is seen as a major player in the AI space, with its technology being pivotal in devices like the Apple iPhone 16. [1]
Market Comeback: Despite early week declines, major indices staged a strong recovery by mid-week. The S&P 500, Dow Jones, and Nasdaq erased most of their earlier losses, with the S&P up 2.7% for the week. This recovery was largely driven by strength in tech and cooling fears of aggressive Fed rate cuts. [1]
These trends reflect how the market is navigating both optimism in the tech sector and cautious anticipation of Federal Reserve actions in the coming weeks.
Whiskey: A Hedge Against Market Volatility
Looking to protect your portfolio from the next recession?
Consider investing in rare spirits like whiskey.
Whiskey investing provides a proven hedge against stock market dips driven by inflation and other factors.
With Vinovest, you can invest in high-growth segments such as American Single Malt, emerging Scotch, Bourbon, and Irish whiskey. Thanks to established industry relationships, Vinovest overcomes industry barriers that have made historically whiskey investing expensive and opaque. As a result, you can enjoy high-quality inventory that boosts your portfolio value and enhances liquidity.
Schedule a call with a Vinovest advisor to learn more.
Top Alerts 🚨
Market-moving alerts received by Uptrends.ai subscribers this past week. Get alerts like these in real-time by subscribing to Uptrends premium here.
1. Instil Bio (TIL)
TIL Surges 500% on Lung Cancer Drug Results
Alert Summary: Instil Bio (TIL) surged to a 52-week high in the past week due to positive developments related to its ITIL-306 program. The company announced a collaboration on preclinical manufacturing feasibility studies, which was seen as a strong step forward in advancing its cancer cell therapy pipeline. This news boosted investor confidence in the potential of Instil's therapies, contributing to the sharp rise in the stock price
🟢 Alert Sentiment: Bullish
🚨 7D Alert Price Change: +161% ▲
2. Big Lots (BIG)
BIG Initiates Chapter 11 Bankruptcy, Sells Assets to Nexus Capital
Summary: Big Lots has initiated a voluntary Chapter 11 bankruptcy filing and agreed to sell its assets to an affiliate of Nexus Capital Management. The retailer also reported a sharper-than-expected drop in sales, driven by a pullback in consumer spending on discretionary items. Additionally, concerns over rising costs and supply chain challenges contributed to the negative sentiment, prompting investors to sell off the stock as the company struggles to regain momentum.
🔴 Alert Sentiment: Bearish
🚨 7D Alert Price Change: -18% ▼
3. Viridian Therapeutics (VRDN)
VRDN Thrives: Positive Results and Future Trials Drive Investor Interest
Summary: VRDN stock price is surging as analyst firms project potential revenue from VRDN-001 to reach $690 million worldwide by 2027. Viridian Therapeutics has completed enrollment for the Phase 3 trial of VRDN-001, with top-line results expected in September 2024. Viridian Therapeutics plans to initiate two critical trials for VRDN-003 in August 2024, aiming to test different dosing regimens for the treatment of TED patients.
🟢 Alert Sentiment: Bullish
🚨 7D Alert Price Change: +15% ▲
MRNA Announces Profitability Delays, Sharp R&D Spending Cuts
Summary: MRNA stock price has fallen this week after the company announced a sharp 20% reduction in its research and development (R&D) budget, alongside delays in achieving profitability, which disappointed investors. Additionally, Moderna's updated revenue guidance for 2025 came in below expectations, largely due to a projected drop in COVID-19 vaccine sales and increased competition. Investors were also concerned about regulatory setbacks for some of its pipeline products, particularly its cancer vaccine in collaboration with Merck, which is now delayed to 2027
🔴 Alert Sentiment: Bearish
🚨 7D Alert Price Change: -13% ▼
IOBT Hits 52-Week Low, Analysts Adjust Price Targets
Summary: Redfin (RDFN) surged significantly over the past week due to a combination of factors. Dovish comments from Federal Reserve Chair Jerome Powell, which eased fears of aggressive interest rate hikes, provided a boost to real estate stocks like Redfin. Additionally, positive analyst upgrades, such as B. Riley Securities raising Redfin's rating to "Buy," further fueled investor optimism. Redfin also announced the expansion of the Redfin Next agent compensation plan nationwide, offering big commission splits with zero expenses.
🟢 Alert Sentiment: Bullish
🚨 7D Alert Price Change: +26% ▲
6. Pro Only 🔒
🔴 Alert Sentiment: Bearish
🚨 7D Alert Price Change: -14% ▼
7. Pro Only 🔒
🔴 Alert Sentiment: Bearish
🚨 7D Alert Price Change: -5% ▼
Beat the Crowd with Uptrends
Want to get alerts like these before they’re priced in? Try setting personalized alerts Uptrends today to unlock real-time custom alerts for your entire portfolio (for free)
